Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.
News
FDA approves encorafenib/binimetinib for advanced melanoma with BRAF mutations
The FDA also approved a companion diagnostic to help identify candidates for the combination therapy.
News
Midlife fitness tied to lower later-life CVD mortality, depression risk
“These findings ... should encourage physicians to consider fitness and physical activity in promoting healthy aging.”
News
FDA: MiniMed 670G now available for younger diabetes patients
The device continuously monitors insulin levels and delivers insulin as needed.
News
Tralokinumab appears safe and effective for atopic dermatitis, in phase 2b study
Greatest improvement seen in patients with high levels of biomarkers associated with IL-13 activity.
News
FDA approves bevacizumab for advanced ovarian cancer
Approval was based on improved PFS for bevacizumab in combination with chemo followed by use as monotherapy in stage III and IV patients.
News
FDA grants regular approval to venetoclax for CLL/SLL
The drug is indicated for patients with CLL or SLL, with or without 17p deletion, who have had at least one prior therapy.
News
CDC concerned about multidrug-resistant Shigella
if clinicians need to use antibiotics to treat patients who have Shigella infections, they should monitor these patients carefully.
News
FDA approves long-acting ESA for dialysis-related anemia in children, adolescents
Mircera is now indicated for dialysis-related anemia in patients aged 5-17 years with chronic kidney disease.
News
Adolescent suicidal ideation and attempts are on the rise
Higher rates were seen during the academic school year.
News
Unusual skin reactions to aluminum patch test seen in some children
The girls were tested because of reactions to vaccines.
News
In COPD, tai chi confers long-term benefit
Tai chi may be better at treating chronic obstructive pulmonary disease than pulmonary rehabilitation.
News
MenB vaccine receives breakthrough therapy designation for children aged 1-9 years
Trumenba is the first MenB vaccine to receive this designation for use in children aged 1-9 years.
News
Upadacitinib for RA shows encouraging results in phase 3 trial
The drug also demonstrated superiority over adalimumab and placebo.
News
U.S. adults consumed 17.5 billion total binge drinks in 2015
Assessing binge-drinking prevalence alone does not capture some disparities in binge-drinking behavior, the coinvestigators concluded.
News
Impact of sleep loss on metabolism is highly individualistic
The findings could have implications for identifying patients who could “at a higher risk of unwanted weight gain and obesity during shift work...